Medical Device Leader Series: Top Needle-Free Injection Device Manufacturers 2014-2024

Medical Device Leader Series: Top Needle-Free Injection Device Manufacturers 2014-2024

Report Details

Needle-free injecting technologies - discover activities, developments, and prospects of leading companies

What does the future hold for makers of needle-free injection (NFI) products? See what's possible. Visiongain's updated report shows you data to 2024 for that industry and market. There you find analysis, trends, opportunities, and forecasting of revenues.

Our study analyses 14 leading developers and producers of those medical devices. You can now explore the future of NFI to introduce drugs, finding its potential. Discover how you can benefit.

Forecasts and other data for staying ahead in knowledge of those medical injectors

There you examine the industry for needleless injection and needle-free syringes - insulin injectors and other systems. Find what's happening. Potential exists for novel and improved subcutaneous, intradermal, intramuscular, and intravenous drug delivery.

That industry advances. In our report you assess product ranges, historical data, R&D, market shares, sales predictions, and growth rates. There you get quantitative and qualitative analyses. You also find 42 tables, 17 charts and three research interviews.

NFI technology - discover how to help your work, also finding where money lies

Avoid missing out. See how developers overcome problems with parenteral drug application, esp. benefiting use of biological drugs (biologics). You also discover potential revenues.

So the following sections outline what you get in our investigation.

Companies based in North America - what're their outlooks?

First our study gives you financial data and discussions for prominent North American NFI developers and manufacturers:
• Antares Pharma
• Bioject Medical Technologies
• Zogenix
• Activa
• D'Antonio Consultants International.

You also find profiles of these organisations:
• National Medical Products
• Medical International Technologies
• Penjet Corporation
• PharmaJet
• Valeritas.

Discover what the present and future hold for those companies. Also find the money. See revenue predictions to 2024 for the overall world industry for needle-free injection devices.

Hear, too, about developments and prospects of competitors in other countries.

Europe - outlooks for leading developers and producers of medical injection technology

Next our report analyses European-based specialists in that drug delivery:
• Akra Dermojet
• Crossject Medical Technology
• Injex Pharma
• Glide Pharma.

Many commercial opportunities exist, with expanding revenues possible this decade. Discover the best potentials. You find how companies gain advantages and raise sales.

In that work you see what affects the future - what influences success.

Events and forces for developing, producing, marketing, and selling NFI technologies

Our study explains issues affecting that industry and market from 2013 onwards, including these:
• Applications - pain management, vaccine delivery, treating diabetes, paediatric medicine, and other therapies
• Regulations in the US and Europe
• Developments stimulating and restraining that market, inc. allied and competing products.

You also investigate these forces:
• Jet injector devices, transdermal patches, microneedles, pen injectors, and other therapeutic systems
• Solid formulations and other challenges, innovations, and progress in therapy
• Deals, collaborations, and other changes affecting that sector.

There you explore political, economic, social, and technological questions, investigating outlooks for business. Examine what stimulates and restrains that industry and market.

You discover, then, what the present and future hold. You also read opinions from our survey of companies. Stay ahead for information.

Ways Medical Device Leader Series:
1. Executive Summary

1.1 Leading NFI Device Manufacturers: Overview of Findings
1.2 Chapters in the Report
1.3 Research and Analysis Methods
1.4 Aims, Scope and Format of the Report
1.5 Glossary of Terms

2. Introduction to Needle-Free Injection

2.1 What is Needle-Free Drug Delivery?
2.1.1 History of Needle-Free Injections: From Military to Clinic
2.1.2 Modern Needle-Free Devices: Concept of High Pressure Fluid Jet
2.2 What is the Rationale for Needle-Free Injections?
2.3 Applications of Needle-Free Drug Delivery
2.3.1 Pain Management: Using NFI Devices to Administer Lidocaine
2.3.2 Vaccine Delivery: Improving Immune Response
2.3.3 Insulin Delivery: Jet Injection Enhances Drug Distribution
2.3.4 Paediatrics: Alleviating Childhood Anxiety and Phobia
2.4 Regulation of Needle-Free Delivery Devices
2.4.1 The US Regulation System: Prolonged Approval Process
2.4.2 The European Regulation System: Manufacturers Seeking EU Approval First?
2.5 Advantages and Disadvantages of Needle-Free Systems

3. The Global Needle-Free Injection Device Market, 2013-2024

3.1 The Global Needle-Free Injection Device Market, 2012
3.2 The Global Needle-Free Injection Device Market: Revenue Forecast, 2013-2024
3.3 How Will the Market Shares of Leading Sectors Change From 2013-2024?
3.4 What Will Drive the Global Needle-Free Injection Device Market Between 2014 and 2024?
3.5 What Factors are Likely to Restrain the Global Needle-Free Injection Device Market Between 2014 and 2024?
3.6 The Global Jet Injector Device Market, 2012
3.6.1 The Global Jet Injector Device Market: Revenue Forecast, 2013-2024
3.6.2 The Global Jet Injector Device Market: Industry Trends, 2013-2024
3.7 The Global Competing Technologies Market, 2012
3.7.1 The Global Competing Technologies Market: Revenue Forecast, 2013-2024
3.7.2 The Global Competing Technologies Market: Industry Trends, 2013-2024 Transdermal Patches: Attractive and Cheap Option Microneedle Technology: Huge Potential for Mass Vaccinations Metered Dose Inhalers: Change in Device Propellant to Drive Adoption

4. The Leading North American Needle-Free Injection Device Manufacturers, 2013

4.1 Antares Pharma
4.1.1 Needle-Free Products Vision™: Delivering Liquid Insulin or Human Growth Hormone Vibex™: Hidden Needle to Alleviate Patient Fear Pen Injector: Devices Being Used Clinical Testing
4.1.2 Sales Performance, 2012
4.1.3 Needle-Free Injection Device Pipeline Vibex™ MTX: Targeting Growing Population of RA Sufferers Vibex™ QS (QuickShot): Modified Vibex to Offer Improved Function OTREXUP™: Combining Vibex MTX and Methotrexate
4.2 Bioject Medical Technologies
4.2.1 Needle-Free Products Biojector® 2000: Adaptable Power Source Allows Use in Home and Mass Vaccination Setting Vitajet™: Low-cost Insulin Delivery System ZetaJet™: Auto-disable Feature Improves User Safety
4.2.2 Sales Performance
4.2.3 Needle-Free Injection Device Pipeline Intradermal Pen Injector: Targeted Drug Delivery Iject®: Providing Tailored Depth of Penetration Jupiter Jet: Multi Dosing With Single Loaded Syringe
4.2.4 Collaborations MPI Research: Seeking Drug/Device Combinations World Health Organisation (WHO): the Push to Eradicate Infectious Disease in Developing Countries
4.3 Zogenix
4.3.1 Needle-Free Products Sumavel® DosePro®: Rapid Acting Migraine Relief
4.3.2 Sales Performance, 2012
4.3.3 Needle-Free Injection Device Pipeline Relday™: Needle-based Alterative for Improved Drug Distribution
4.3.4 Collaborations
4.3.5 Manufacturing
4.4 Activa Brand Products, Inc.
4.4.1 Technology: the Activa Family for Diabetics
4.4.2 Needle-Free Products Pro